SNUEI

IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin–directed vascular barrier disruption

2019 · Journal of Clinical Investigation

저자

Victoria Langer, Eugenia Vivi, Daniela Regensburger, Thomas Winkler, Maximilian J. Waldner, Timo Räth, Benjamin Schmid, Lisa Skottke, Somin Lee, 전누리 (Noo Li Jeon), Thomas Wohlfahrt, Viktoria Kramer, Philipp Tripal, Michael Schümann, Stephan Kersting, Claudia Handtrack, Carol Immanuel Geppert, Karina Suchowski, Ralf H. Adams, Christoph Becker, Andreas Ramming, Elisabeth Naschberger, Nathalie Britzen‐Laurent, Michael Stürzl

연구주제

–

NTIS 과학기술표준분류

에너지/자원만에너지·환경·원자력 확장

지원 과제·AI 키워드로 잡을 근거가 없어 분류하지 않았다.

AI 연구 키워드·방법

inflammatory bowel disease interferon gamma signaling vascular barrier disruption

키워드 (OpenAlex)

inflammatory bowel disease interferon-gamma VE-cadherin adherens junctions endothelial cells experimental colitis vascular permeability imatinib

초록

Inflammatory bowel disease (IBD) is a chronic inflammatory disorder with rising incidence. Diseased tissues are heavily vascularized. Surprisingly, the pathogenic impact of the vasculature in IBD and the underlying regulatory mechanisms remain largely unknown. IFN-γ is a major cytokine in IBD pathogenesis, but in the context of the disease, it is almost exclusively its immune-modulatory and epithelial cell-directed functions that have been considered. Recent studies by our group demonstrated that IFN-γ also exerts potent effects on blood vessels. Based on these considerations, we analyzed the vessel-directed pathogenic functions of IFN-γ and found that it drives IBD pathogenesis through vascular barrier disruption. Specifically, we show that inhibition of the IFN-γ response in vessels by endothelial-specific knockout of IFN-γ receptor 2 ameliorates experimentally induced colitis in mice.…

이 논문을 지원한 국가R&D 과제 (NTIS 성과)

NTIS 성과DB(2020–24)에서 DOI 매칭 없음

인접 그래프

노드 hover = 이웃 강조 · 1회 클릭 = 고정 · 고정된 노드 다시 클릭 = 페이지 이동

이 문서와 연결된 페이지

교수 1

전누리